Goldman Sachs upgraded Evonik (EVKIF) to Buy from Sell with a price target of EUR 18, up from EUR 11.60. The firm adjusted seven ratings in the European chemicals group, shifting its sector view to a pro-cyclical stance from a previously defensive stance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVKIF: